Episode
Cerebral Organoids Provide New Strategy to Personalize Glioblastoma Treatment
- Podcast
- Advances in Care
- Published
- May 28, 2026
- Duration seconds
- 1139
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/advances-in-care-6039100/episodes/cerebral-organoids-provide-new-strategy-to-personalize-glioblastoma-treatment/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/advances-in-care-6039100/cerebral-organoids-provide-new-strategy-to-personalize-glioblastoma-treatment.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
On this episode of Advances in Care, Erin Welsh speaks with Dr. Howard Fine, neuro-oncologist at NewYork-Presbyterian and director of the Brain Tumor Center at Weill Cornell Medicine, about his groundbreaking research in glioblastoma. Dr. Fine’s lab is bioengineering cerebral organoids - called mini brains - from human embryonic stem cells through a platform called GLICO, which creates genetically matched, patient-specific brain models using an individual's immune cells and glioma cells. These miniature replicas allow researchers to map how a tumor may progress, and test new, individualized therapeutic approaches, offering a hope for transforming glioblastoma into a manageable disease and improving overall survivorship.